Drug Trial Radar · NCT05629390
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
Last checked: Nov 20, 2026Latest source record: May 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
163
Actual
Start
Oct 23, 2022
Primary completion
Sep 15, 2023
Study completion Apr 2, 2024
Sponsor
- Lead sponsor
- LianBio LLCIndustry
- Sponsor type
- Industry
- First posted
- Nov 29, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Phase III main study is a randomized, controlled, multicenter, double blind, trial to evaluate the efficacy and safety of TP-03 (lotilaner ophthalmic solution, 0.25%), for the treatment of Demodex blepharitis in Chinese patients. The PK sub-study is a single-arm, open-label trial to evaluate systemic TP-03 in whole blood following topical ocular administration
Conditions
- Blepharitis
Interventions
LotilanerDrug
Lotilaner Ophthalmic Solution
Vehicle ControlDrug
Vehicle of TP-03 ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of participants cured based on their collarette score of 0 for the upper eyelid of the analysis eye.Time frame: 43 days
- The proportion of participants with Demodex eradication based on the mite density of 0 mites/lash for the analysis eye at Day 43Time frame: 43 days
- The assessment of treatment-related adverse effectsTime frame: 43 days
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tongren Hospital
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Chongqing Aier Eye Hospital
Chongqing, Chongqing Municipality, China
Xiamen Eye Center of Xiamen University
Xiamen, Fujian, China
Guangzhou Aier Eye Hospital
Guangzhou, Guangdong, China
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Hainan Eye Hospital
Haikou, Hainan, China
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Henan Provincial Eye Hospital
Zhengzhou, Henan, China
Union Hospital, Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Xiangya Hospital, Central South University
Changsha, Hunan, China
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China
Wuxi Second People's Hospital
Wuxi, Jiangsu, China
Eye& Ent Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Shanxi Provincial Eye Hospital
Taiyuan, Shanxi, China
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Eye Hospital, Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.